Carl Zeiss Meditec AG

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DE0005313704
EUR
43.30
0.36 (0.84%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Sep'18
Net Sales
2,066.13
2,089.30
1,902.84
1,646.79
1,335.45
1,459.32
1,280.86
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,066.13
2,089.30
1,902.84
1,646.79
1,335.45
1,459.32
1,280.86
Raw Material Cost
977.50
883.53
775.24
679.57
589.93
627.44
570.47
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
616.26
527.63
437.60
378.47
352.65
347.53
311.24
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
29.42
15.25
9.10
8.58
27.27
7.65
2.05
Selling and Distribution Expenses
514.81
493.56
429.46
356.48
342.96
393.91
353.65
Other Expenses
-30.26
-19.36
-15.53
-15.50
-16.11
-18.19
-15.37
Total Expenditure (Excl Depreciation)
1,835.39
1,726.37
1,496.06
1,268.12
1,151.70
1,194.66
1,083.74
Operating Profit (PBDIT) excl Other Income
230.7
362.9
406.8
378.7
183.79999999999998
264.7
197.10000000000002
Other Income
61.77
76.28
14.41
-23.54
28.43
-27.15
-15.88
Operating Profit (PBDIT)
425.27
513.27
490.96
416.71
272.61
285.88
212.52
Interest
29.42
15.25
9.10
8.58
27.27
7.65
2.05
Exceptional Items
-19.19
-10.50
-8.60
-7.50
-6.20
0.00
0.00
Gross Profit (PBDT)
1,088.63
1,205.77
1,127.60
967.21
745.52
831.88
710.39
Depreciation
132.77
74.06
69.77
61.58
60.42
48.37
31.28
Profit Before Tax
243.89
413.46
403.49
339.05
178.72
229.86
179.18
Tax
60.71
120.56
107.58
101.53
55.30
69.28
52.95
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
178.73
290.40
293.91
236.28
122.39
159.76
126.46
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
178.73
290.40
293.91
236.28
122.39
159.76
126.46
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.43
1.61
2.00
1.24
1.04
0.82
-0.23
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
180.15
292.01
295.91
237.52
123.42
160.58
126.23
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,041.70
2,159.45
2,015.10
1,659.33
1,431.72
1,398.44
1,293.46
Earnings per share (EPS)
2.01
3.25
3.29
2.64
1.37
1.79
1.41
Diluted Earnings per share
2.01
3.25
3.29
2.64
1.37
1.79
1.41
Operating Profit Margin (Excl OI)
11.17%
17.37%
21.38%
22.99%
13.76%
18.14%
15.39%
Gross Profit Margin
18.23%
23.33%
24.87%
24.33%
17.91%
19.07%
16.43%
PAT Margin
8.65%
13.9%
15.45%
14.35%
9.16%
10.95%
9.87%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Sep 2024 is -1.11% vs 9.80% in Sep 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Sep 2024 is -38.29% vs -1.32% in Sep 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Sep 2024 is -16.82% vs -8.29% in Sep 2023

stock-summary

Interest

YoY Growth in year ended Sep 2024 is 93.42% vs 67.03% in Sep 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Sep 2024 has fallen from Sep 2023

Compare Annual Results Of Carl Zeiss Meditec AG With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(EUR)
Change(%)
Net Sales
2,066.13
21,833.00
-19,766.87
-90.54%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,066.13
21,833.00
-19,766.87
-90.54%
Raw Material Cost
977.50
16,455.00
-15,477.50
-94.06%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
616.26
9,586.00
-8,969.74
-93.57%
Power Cost
0
0
0.00
Manufacturing Expenses
29.42
543.00
-513.58
-94.58%
Selling and Distribution Expenses
514.81
2,901.00
-2,386.19
-82.25%
Other Expenses
-30.26
-948.80
918.54
96.81%
Total Expenditure (Excl Depreciation)
1,835.39
19,997.00
-18,161.61
-90.82%
Operating Profit (PBDIT) excl Other Income
230.73
1,836.00
-1,605.27
-87.43%
Other Income
61.77
69.00
-7.23
-10.48%
Operating Profit (PBDIT)
425.27
3,109.00
-2,683.73
-86.32%
Interest
29.42
543.00
-513.58
-94.58%
Exceptional Items
-19.19
-12.00
-7.19
-59.92%
Gross Profit (PBDT)
1,088.63
5,378.00
-4,289.37
-79.76%
Depreciation
132.77
1,204.00
-1,071.23
-88.97%
Profit Before Tax
243.89
1,350.00
-1,106.11
-81.93%
Tax
60.71
521.00
-460.29
-88.35%
Provisions and contingencies
0
0
0.00
Profit After Tax
178.73
1,042.00
-863.27
-82.85%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
178.73
1,042.00
-863.27
-82.85%
Share in Profit of Associates
0
0
0.00
Minority Interest
1.43
-175.00
176.43
100.82%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
180.15
867.00
-686.85
-79.22%
Equity Capital
0
0
0.00
Face Value
1.00
1.00
0.00
Reserves
2,041.70
19,542.00
-17,500.30
-89.55%
Earnings per share (EPS)
2.01
0.84
1.17
139.29%
Diluted Earnings per share
2.01
0.84
1.17
139.29%
Operating Profit Margin (Excl OI)
11.17%
8.41%
0.00
2.76%
Gross Profit Margin
18.23%
11.70%
0.00
6.53%
PAT Margin
8.65%
4.77%
0.00
3.88%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 206.61 Million
in Sep 2024

Figures in Million
stock-summary

YoY Growth in year ended Sep 2024 is -1.11% vs 9.80% in Sep 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 18.02 Million
in Sep 2024

Figures in Million
stock-summary

YoY Growth in year ended Sep 2024 is -38.29% vs -1.32% in Sep 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 36.35 Million
in Sep 2024

Figures in Million
stock-summary

YoY Growth in year ended Sep 2024 is -16.82% vs -8.29% in Sep 2023

Annual - Interest
Interest 2.94 Million
in Sep 2024

Figures in Million
stock-summary

YoY Growth in year ended Sep 2024 is 93.42% vs 67.03% in Sep 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.17%
in Sep 2024

Figures in %
stock-summary

YoY Growth in year ended Sep 2024 has fallen from Sep 2023